Market Currents
Novartis (NVS) plans to file for Japanese and EU approval of QVA149 - a therapy that combines...
-
Thursday, August 30, 2012, 8:30 AM ETNovartis (NVS) plans to file for Japanese and EU approval of QVA149 - a therapy that combines two of the company's other drugs and is used to treat smoker's cough - later this year after it met expectations in final trials. Yesterday, the FDA authorized a new dosage of Novartis' cancer drug Afinitor so it can be used to treat children with a rare brain tumor. (PR)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
